Clinical evidence shows that glutathione IV therapy can improve liver markers, such as decreasing ALT (a liver inflammation indicator), and enhance cellular repair, especially beneficial for conditions like fatty liver disease
Hartweg J, Farmer AJ, Holman RR, and Neil HAW
NAC and metabolic parameters: NAC has been more extensively studied for metabolic health
FDA Regulatory Status The FDAs position is unambiguous: BPC-157 is not an approved drug for any medical condition
poor nutrition or vegan diet) Transcobalamin II deficiency It is also used as part of the vitamin B12 absorption test (Schilling test)
In the second tier sit peptides like Thymosin Alpha-1, which have regulatory approval for specific indications, meaningful human trial data, and plausible longevity mechanisms even if their specific application to healthy aging remains to be formally tested